Outcomes of Transcatheter Aortic Valve Implantation in Patients With Low Versus Intermediate to High Surgical Risk

2019 ◽  
Vol 123 (4) ◽  
pp. 644-649 ◽  
Author(s):  
Ariel Finkelstein ◽  
Zach Rozenbaum ◽  
Amir Halkin ◽  
Shmuel Banai ◽  
Samuel Bazan ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
High Surgical Risk ◽  
Aortic Valve Implantation ◽  
Valve Implantation

scholarly journals Endovascular Bail Out for a Failed Transcatheter Aortic Valve Implantation in High Surgical Risk Patient

2021 ◽  
Vol 2021 ◽  
pp. 1-4
Author(s):  
Ilaria Peluttiero ◽  
Alessandro Robaldo ◽  
Luigi Leotta ◽  
Claudio Novali
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Acute Type ◽  
Emergency Setting ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
Acute Type A Dissection ◽  
High Surgical Risk ◽  
Aortic Valve Implantation ◽  
Valve Implantation

The endovascular treatment for acute type A dissection (ATAD) represents an alternative and emerging option in selected high surgical risk patients. We report a successful total endovascular ATAD repair occurred intraoperatively during transcatheter aortic valve implantation (TAVI) placement in 82 years old female, not fit for surgery in emergency setting. The presentation, the diagnostic evaluation, and the technique are discussed. This case would support the feasibility and efficacy of the stent graft technology to treat ATADs after evaluation of clinical, anatomical, and radiological parameters.

scholarly journals Adoption of Transcatheter Aortic Valve Implantation in Western Europe

2011 ◽  
Vol 9 (1) ◽  
pp. 37 ◽  
Author(s):  
Darren Mylotte ◽  
Ruben LJ Osnabrugge ◽  
Giuseppe Martucci ◽  
Ruediger Lange ◽  
Arie Pieter Kappetein ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Transcatheter Aortic Valve Implantation ◽  
Western Europe ◽  
Therapeutic Option ◽  
Surgical Aortic Valve Replacement ◽  
Surgical Risk ◽  
Transcatheter Aortic Valve ◽  
High Surgical Risk ◽  
Aortic Valve Implantation ◽  
Valve Implantation

Transcatheter aortic valve implantation (TAVI) is a novel therapeutic option for patients with severe symptomatic aortic stenosis (AS) at excessive or high surgical risk for conventional surgical aortic valve replacement. First commercialised in Europe in 2007, TAVI growth has been exponential among some Western European nations, though recent evidence suggests heterogeneous adoption of this new and expensive therapy. Herein, we review the evidence describing the utilisation of TAVI in Western Europe.

Sign in / Sign up

Export Citation Format

Share Document